A Reversal for Ekf Diagnostics Holding PLC Is Not Near. The Stock Reaches 52-Week High Today

 A Reversal for Ekf Diagnostics Holding PLC Is Not Near. The Stock Reaches 52 Week High Today

The stock of Ekf Diagnostics Holding PLC (LON:EKF) hit a new 52-week high and has GBX 36.72 target or 107.00% above today’s GBX 17.74 share price. The 8 months bullish chart indicates low risk for the GBX 82.68 million company. The 1-year high was reported on Nov, 8 by Barchart.com. If the GBX 36.72 price target is reached, the company will be worth GBX 88.47 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock decreased 1.44% or GBX 0.26 on November 8, hitting GBX 17.74. About 155,175 shares traded hands. Ekf Diagnostics Holding PLC (LON:EKF) has risen 42.57% since April 8, 2016 and is uptrending. It has outperformed by 40.62% the S&P500.

Ekf Diagnostics Holding PLC (LON:EKF) Ratings Coverage

Out of 3 analysts covering EKF Diagnostics Holdings PLC (LON:EKF), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. GBX 30 is the highest target while GBX 14 is the lowest. The GBX 24 average target is 35.29% above today’s (GBX 17.74) stock price. EKF Diagnostics Holdings PLC has been the topic of 28 analyst reports since August 19, 2015 according to StockzIntelligence Inc. The rating was maintained by FinnCap with “Buy” on Monday, September 28. FinnCap maintained Ekf Diagnostics Holding PLC (LON:EKF) on Wednesday, August 19 with “Buy” rating. The firm has “Buy” rating given on Thursday, September 3 by FinnCap. Panmure Gordon maintained it with “Buy” rating and GBX 14 target price in Monday, September 5 report. On Tuesday, November 17 the stock rating was maintained by FinnCap with “Buy”. The firm earned “Hold” rating on Wednesday, August 19 by N+1 Singer. FinnCap maintained it with “Buy” rating and GBX 30 target price in Friday, September 18 report. N+1 Singer maintained it with “Hold” rating and GBX 23 target price in Monday, October 26 report. The firm earned “Hold” rating on Thursday, November 26 by N+1 Singer. Panmure Gordon maintained Ekf Diagnostics Holding PLC (LON:EKF) on Monday, November 7 with “Buy” rating.

More important recent Ekf Diagnostics Holding PLC (LON:EKF) news were published by: Fool.Co.Uk which released: “Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?” on October 07, 2016, also Fool.Co.Uk published article titled: “Why Shares In EKF Diagnostics Holding PLC Halved Today”, Fool.Co.Uk published: “Are These 3 Small-Caps Set To Soar? EKF Diagnostics Holding PLC, Hardy Oil …” on March 18, 2016. More interesting news about Ekf Diagnostics Holding PLC (LON:EKF) was released by: Fool.Co.Uk and their article: “Should you buy Topps Tiles plc, EKF Diagnostics Holding plc and Low & Bonar …” with publication date: July 06, 2016.

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of services and products into the in-vitro diagnostic market place. The company has a market cap of 82.68 million GBP. The Firm makes and sells diagnostic instruments, reagents and certain ancillary products. It currently has negative earnings. The Company’s point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment